drugset / Trial / NCT02122393

A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression

NCT02122393

Phase 3 Completed 45 enrolled University of Melbourne Pfizer · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

Th purpose of this study is to determine whether dual psychological and pharmacological treatment is superior to either mono-therapy alone in the treatment of postnatal depression.

Timeline

Start
2002-04
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sertraline Small molecule